Company Filing History:
Years Active: 1989-1992
Title: Senkichi Nagasaki: Innovator in Quantitative Analysis
Introduction
Senkichi Nagasaki is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of quantitative analysis, particularly in the area of steroid analysis. With a total of 2 patents, his work has implications for liver function testing and other medical applications.
Latest Patents
Nagasaki's latest patents include a method and reagent for the quantitative analysis of 3-oxo-5.beta.-steroid. This method involves the action of 3-oxo-5.beta.-steroid.DELTA..sup.4 -dehydrogenase on a sample in the presence of a reducing chromophoric agent, allowing for the measurement of the optical density of the resulting chromophoric substance. A typical reducing chromophoric agent used in this process is a tetrazolium compound. This invention provides a simple and reliable method for liver function tests. Another significant patent focuses on the quantitative analysis of 3.alpha.-hydroxysteroid, which can be achieved by using 3.alpha.-hydroxysteroid dehydrogenase in conjunction with nicotinamide adenine dinucleotide and other electron carrier substances.
Career Highlights
Senkichi Nagasaki is currently associated with Daiichi Pure Chemicals Co., Ltd. His work at this company has allowed him to develop innovative methods that enhance the accuracy and reliability of quantitative analyses in medical testing.
Collaborations
Nagasaki has collaborated with notable coworkers such as Koji Ushizawa and Toshiyuki Akimoto. Their combined expertise has contributed to the advancement of research in the field of quantitative analysis.
Conclusion
Senkichi Nagasaki's contributions to the field of quantitative analysis through his innovative patents have made a significant impact on medical testing. His work continues to influence the development of reliable methods for analyzing important biological substances.